98%
921
2 minutes
20
Introduction: Altered neurometabolism, detectable via proton magnetic resonance spectroscopic imaging (H-MRSI), is spatially heterogeneous and underpins cognitive impairments in Alzheimer's disease (AD). However, the spatial relationships between neurometabolic topography and cognitive impairment in AD remain unexplored due to technical limitations.
Methods: We used a novel whole-brain high-resolution H-MRSI technique, with simultaneously acquired F-florbetapir positron emission tomography (PET) imaging, to investigate the relationship between neurometabolic topography and cognitive functions in 117 participants, including 22 prodromal AD, 51 AD dementia, and 44 controls.
Results: Prodromal AD and AD dementia patients exhibited spatially distinct reductions in N-acetylaspartate, and increases in myo-inositol. Reduced N-acetylaspartate and increased myo-inositol were associated with worse global cognitive performance, and N-acetylaspartate correlated with five specific cognitive scores. Neurometabolic topography provides biological insights into diverse cognitive dysfunctions.
Discussion: Whole-brain high-resolution H-MRSI revealed spatially distinct neurometabolic topographies associated with cognitive decline in AD, suggesting potential for noninvasive brain metabolic imaging to track AD progression.
Highlights: Whole-brain high-resolution H-MRSI unveils neurometabolic topography in AD. Spatially distinct reductions in NAA, and increases in mI, are demonstrated. NAA and mI topography correlates with global cognitive performance. NAA topography correlates with specific cognitive performance.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497670 | PMC |
http://dx.doi.org/10.1002/alz.14137 | DOI Listing |
Adv Sci (Weinh)
July 2025
Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Cerebral glucose metabolism (CMRGlc) systematically decreases with advancing age. We sought to identify correlates of decreased CMRGlc in the spectral properties of fMRI signals imaged in the task-free state. Lifespan resting-state fMRI data acquired in 455 healthy adults (ages 18-87 years) and cerebral metabolic data acquired in a separate cohort of 94 healthy adults (ages 25-45 years, 65-85 years) were analyzed.
View Article and Find Full Text PDFCerebral glucose metabolism (CMRGlc) systematically decreases with advancing age. We sought to identify correlates of decreased CMRGlc in the spectral properties of fMRI signals imaged in the task-free state. We analyzed lifespan resting-state fMRI data acquired in 455 healthy adults (ages 18-87 years) and cerebral metabolic data acquired in a separate cohort of 94 healthy adults (ages 25-45 years, 65-85 years).
View Article and Find Full Text PDFAlzheimers Dement
September 2024
National Engineering Research Center of Advanced Magnetic Resonance Technologies for Diagnosis and Therapy, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Introduction: Altered neurometabolism, detectable via proton magnetic resonance spectroscopic imaging (H-MRSI), is spatially heterogeneous and underpins cognitive impairments in Alzheimer's disease (AD). However, the spatial relationships between neurometabolic topography and cognitive impairment in AD remain unexplored due to technical limitations.
Methods: We used a novel whole-brain high-resolution H-MRSI technique, with simultaneously acquired F-florbetapir positron emission tomography (PET) imaging, to investigate the relationship between neurometabolic topography and cognitive functions in 117 participants, including 22 prodromal AD, 51 AD dementia, and 44 controls.
Pediatr Radiol
October 2015
Medical Genetics Unit, Pediatric Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.
Background: Glutaric aciduria type 1 is a rare neurometabolic disease with high morbidity.
Objective: To describe the MR imaging abnormalities in glutaric aciduria type 1 and to identify any association between the clinical and imaging features.
Materials And Methods: MRI scans of 29 children (mean age: 16.
Clin Perinatol
June 2006
Department of Pediatric Medicine, Dartmouth Medical School Children's Hospital at Dartmouth Hitchcock Medical Center, Lebanon, NH 03756-0001, USA.
This article is designed to be a basic introduction to neurometabolic diseases (ie, inheritable inborn errors of metabolism, genetic disorders of developmental neural topography, and degenerative disorders of neural function) that present in the neonate. It is intended to assist those who provide primary care for newborns to help them recognize signs and symptoms that signify neurometabolic disease; to teach how and when to initiate a neurometabolic diagnostic sequence; and to help neurologists and pediatricians interface with geneticists and metabolists. This article is intended to inform general newborn care practitioners, not metabolists.
View Article and Find Full Text PDF